JPRN-UMIN000011832已完成未知
A study about immunogenicity and safety of Phase 3 and 4 immunization with combined measles-rubella vaccine - A study about immunogenicity and safety of Phase 3 and 4 immunization with MR vaccine
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
We will present the results at the 17th annual meeting of the Japanese Society for Vacccinology on November 30, 2013.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 12years-old 至 19years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •We exclude the subjects from whom we could not obtain the paired serum samples (before and 4-6 weeks after the immunization).
研究者
相似试验
已完成
不适用
A study about immunogenicity and safety of an additional varicella vaccinatiovaricellaJPRN-UMIN000009888Konan Kosei Hospital30
已完成
3 期
A Study of 2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)Hepatitis A Virus InfectionNCT00835380Merck Sharp & Dohme LLC80
Enrolling By Invitation
3 期
Phase 3 study, to evaluate the safety and immunogenicity of 10 mcg HXP-GPOVac COVID-19 vaccine boost in comparison to a viral vector-based COVID-19 vaccinesHealthy male and female subjectsTCTR20221026004The Government Pharmaceutical Organization4,000
尚未招募
3 期
Phase 3 study, to evaluate the safety and immunogenicity of HXP-GPOVac vaccine in comparison to AstraZeneca's AZD1222 COVID-19 vaccineHealthy male and female subjectsTCTR20220120002The Government Pharmaceutical Organization4,000
已完成
3 期
Ross River Virus (RRV) Vaccine StudyProphylaxis of Ross River Virus InfectionNCT01242670Resilience Government Services, Inc.1,968